Analysed Novo Nordisk A/S (NONOF:OTCMKTS) News Sources
Novo Nordisk's CagriSema Trial Deals Blow in Obesity Drug Battle With Eli Lilly
U.S. News & World Report
Why did NVO stock crash over 14% today? Novo Nordisk’s weight-loss drug CagriSema misses trial goal against Eli Lilly’s Tirzepatide
The Economic Times on MSN
Investors heavily search Novo Nordisk A/S (NVO): Here is what you need to know
Zacks Investment Research on MSN
What is the current price of Novo Nordisk A/S (NONOF:OTCMKTS)?
The current price of Novo Nordisk A/S (NONOF:OTCMKTS) is $37.81.
Novo Nordisk A/S (NONOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Novo Nordisk A/S (NONOF:OTCMKTS) since the previous trading day is $-0.47.
Novo Nordisk A/S (NONOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Novo Nordisk A/S (NONOF:OTCMKTS) since the previous trading day is -1.23%.
What is This Week's average sentiment score for Novo Nordisk A/S (NONOF:OTCMKTS)?
This Week's average sentiment score for Novo Nordisk A/S (NONOF:OTCMKTS) is 35 out of 100.
What is This Week's average sentiment for Novo Nordisk A/S (NONOF:OTCMKTS)?
This Week's sentiment for Novo Nordisk A/S (NONOF:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.